BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 06, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Traversa Therapeutics Inc.

La Jolla, Calif.

Technology: Peptide transduction domain linked to a double-stranded RNA binding domain...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >